Involvement of interleukin-1β in the mechanism of human immunodeficiency virus type 1 (HIV-1) recombinant protein gp120-induced apoptosis in the neocortex of rat

Neuroscience

Volumn 89, Issue 4, 1999, Pages 1051-1066

  Bagetta, G ^a,b   Corasaniti, M T ^c   Berliocchi, L ^b   Nistico R ^b   Giammarioli, A M ^d   Malorni, W ^d   Aloe, L ^c   Finazzi Agro A ^e  

^a UNIVERSITY OF CALABRIA   (Italy)

^b Mondino Tor Vergata Center for Experimental Neuropharmacology   (Italy)

^c CNR   (Italy)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Apoptosis; HIV 1 gp120 coat protein; IL 1 ; NGF; Nitric oxide

Indexed keywords

GLYCOPROTEIN GP 120; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; LEUPEPTIN; NERVE GROWTH FACTOR; NITRIC OXIDE; BOVINE SERUM ALBUMIN; CITRULLINE; IL1RN PROTEIN, HUMAN; INTERLEUKIN 1; RECOMBINANT PROTEIN; SIALOGLYCOPROTEIN;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; BODY TEMPERATURE; BRAIN CORTEX; BRAIN SLICE; CONTROLLED STUDY; DNA DAMAGE; HIPPOCAMPUS; HUMAN IMMUNODEFICIENCY VIRUS 1; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROGLIA; NEOCORTEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; TRANSMISSION ELECTRON MICROSCOPY; ANIMAL; BIOSYNTHESIS; CATTLE; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOLOGY; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; KINETICS; METABOLISM; NICK END LABELING; PATHOLOGY; PHYSIOLOGY; TIME; WISTAR RAT;

ANIMALS; APOPTOSIS; BODY TEMPERATURE; CATTLE; CITRULLINE; GENE EXPRESSION REGULATION; HIV ENVELOPE PROTEIN GP120; HUMANS; IN SITU NICK-END LABELING; INJECTIONS, INTRAVENTRICULAR; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; KINETICS; LEUPEPTINS; MALE; MICROGLIA; NEOCORTEX; RATS; RATS, WISTAR; RECOMBINANT PROTEINS; SERUM ALBUMIN, BOVINE; SIALOGLYCOPROTEINS; TIME FACTORS;

EID: 0032587645     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(98)00363-7     Document Type: Article

References (57)

1. Bagetta G., Corasaniti M.T., Aloe L., Berliocchi L., Costa N., Finazzi-Agrò A., Nisticò G. Intracerebral injection of human immunodeficiency virus type 1 coat protein gp120 differentially affects the expression of nerve growth factor and nitric oxide synthase in the hippocampus of rat. Proc. natn. Acad. Sci. U.S.A. 93:1996;928-933.
2. Bagetta G., Corasaniti M.T., Berliocchi L., Navarra M., Finazzi-Agrò A., Nisticò G. HIV-1 gp120 produces DNA fragmentation in the cerebral cortex of rat. Biochem. biophys. Res. Commun. 211:1995;130-136.
3. Bagetta G., Corasaniti M.T., Costa N., Berliocchi L., Finazzi-Agrò A., Nisticò G. The human immunodeficiency virus type 1 (HIV-1) glycoprotein gp120 reduces the expression of neuronal nitric oxide synthase in the hippocampus but not in the cerebral cortex and medial septal nucleus of rat. Neurosci. Lett. 224:1997;75-78.
4. Bagetta G., Corasaniti M.T., Malorni W., Rainaldi G., Costa N., Berliocchi L., Finazzi-Agrò A., Nisticò G. The HIV-1 gp120 causes ultrastructural changes typical of apoptosis in the rat cerebral cortex. NeuroReport. 7:1996;1722-1724.
5. Bagetta G., Nisticò G., Bowery N.G. CGP37849, a competitive NMDA receptor antagonist prevents the behavioural and neurodegenerative effects of tetanus toxin in rat hippocampus. Molec. Neuropharmac. 1:1991;45-51.
6. Bagetta G., Rodinò P., Paoletti A.M., Arabia A., Massoud R., Nisticò G. Systemic administration of lithium and tacrine but not kainic acid augments citrulline content in the brain of rat. Eur. J. Pharmac. 294:1995;341-344.
7. Bershadsky A. D. and Vasiliev J. M. (1988) In Cytoskeleton (ed. Siekevitz P.), pp. 133-154. Plenum, New York.
8. Betz A.L., Yang G.-Y., Davdson B.L. Attenuation of stroke size in rats using an adenoviral vector to induce overexpression of interleukin-1 receptor antagonist in brain. J. cerebr. Blood Flow Metab. 15:1995;547-551.
9. Black R.A., Kronheim S.R., Cantrell M., Deeley M.C., March C.J., Prickett K.S., Wignall J., Conlon P.J., Cosman D., Hopp T.P., Mochizuki D.Y. Generation of biologically active interleukin-1 of IL-1β by proteolytic cleavage of the inactive precursor. J. biol. Chem. 263:1988;9437-9442.
10. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P.L., Lipton S.A. Apoptosis and necrosis: two distinct events induced respectively by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. natn. Acad. Sci. U.S.A. 92:1995;7162-7166.
11. Cheng B., Mattson M.P. NGF and bFGF protect rat hippocampal and human cortical neurons against hypoglicemic damage by stabilizing calcium homeostasis. Neuron. 7:1991;1031-1041.
12. Cuello A.C. Trophic responses of forebrain cholinergic neurons: a discussion. Prog. Brain Res. 98:1993;265-277.
13. Dimmeler S., Haendeler J., Nehls M., Zeiher A.M. Suppression of apoptosis by nitric oxide via inhibition of interleukin 1 of IL-1β-converting enzyme (ICE)-like and cysteine protease protein (CPP)-32-like proteases. J. exp. Med. 185:1997;601-607.
14. Dinarello C.A. Interleukin-1. Rev. Infect. Dis. 6:1984;51-95.
15. Dripps D.J., Brandhuber B.C., Thompson R.C., Eisenberg S.P. Interleukin-1 receptor antagonist binds to the 80kDa interleukin-1 receptor, but does not initiate interleukin-1 signal transduction. J. biol. Chem. 266:1991;10331-10336.
16. Epstein L.G., Gendelman H.E. Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms. Ann. Neurol. 33:1993;429-436.
17. Gagliardini V., Fernandez P.A., Lee R.K., Drexler H.C., Rotello R.J., Fishman M.C., Yuan J. Prevention of vertebrate neuronal death by the crmA gene. Science. 263:1994;826-828.
18. Gavrieli Y., Sherman Y., Ben-Sasson S.A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J. Cell Biol. 119:1992;493-501.
19. Genis P., Jett M., Bernton E.W., Boyle T., Gelbard H.A., Dzenko K., Keane R.W., Resnick L., Mizrachi Y., Volsky D.J., Epstein L.G., Gendelman H.E. Cytokines and arachidonic acid metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J. exp. Med. 176:1992;1703-1718.
20. Giulian D., Wendt E., Vaca K., Noonan C.A. The envelope glycoprotein of human immunodeficiency virus type one stimulates release of neurotoxins from monocytes. Proc. natn. Acad. Sci. U.S.A. 90:1993;2769-2773.
21. Giulian D., Young D.G., Woodward J., Brown D.C., Lachman L.B. Interleukin-1 is an astroglial growth factor in the developing brain. J. Neurosci. 8:1988;709-714.
22. Glowa J.R., Panlilio L.V., Brenneman D.E., Gozes I., Fridkin M., Hill J.M. Learning impairment following intracerebral administration of the HIV envelope protein gp120 or VIP antagonist. Brain Res. 603:1992;222-233.
23. Griffin S.W., Stanley L.C., Ling C., White C., MacLeod V., Perrot L.J., White C.L., Araoz C. Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc. natn. Acad. Sci. U.S.A. 86:1989;7611-7615.
24. Hagan P., Poole S., Bristow A.F., Tilders F., Silverstein F.S. Intracerebral NMDA injection stimulates production of interleukin-1b in perinatal rat brain. J. Neurochem. 67:1996;2215-2218.
25. Hill J.M., Mervis R.F., Avidor R., Moody T.W., Brenneman D.E. HIV envelope protein-induced neuronal damage and retardation of behavioural development in rat neonates. Brain Res. 603:1993;222-233.
26. Kerr J. F. R., Searle J., Harmon B. V. and Bishop C. J. (1987) In Perspectives on Mammalian Cell Death (ed. Potten C. S.), pp. 93-128. Oxford University Press, Oxford.
27. Knowles R.G., Moncada S. Nitric oxide synthases in mammals. Biochem. J. 298:1994;249-258.
28. Kostura M.J., Tocci M.J., Limjuci G., Chin J., Cameron P., Hillman A.G., Chartrain N.A., Schmidt J.A. Identification of a monocyte specific pre-interleukin 1 of IL-1β convertase activity. Proc. natn. Acad. Sci. U.S.A. 86:1989;5227-5231.
29. Lee T.-H., Abe K., Kogure K., Itoyama Y. Expression of nerve growth factor and p75 low affinity receptor after transient forebrain ischemia in gerbil hippocampal CA1 neurons. J. Neurosci. Res. 41:1995;684-695.
30. Lindholm D., Heumann R., Metyer M., Thoenen H. Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve. Nature. 330:1987;658-659.
31. Lipton S.A., Gendelman H.E. Dementia associated with the acquired immunodeficiency syndrome. New Engl. J. Med. 332:1995;934-940.
32. Martins L.M., Earnshow W.C. Apoptosis: alive and kicking in 1997. Trends Cell Biol. 7:1997;111-114.
33. Melino G., Bernassola F., Knight R.A., Corasaniti M.T., Nisticò G., Finazzi-Agrò A. S-nitrosylation regulates apoptosis. Nature. 388:1997;432-433.
34. Merrill J.E., Chen I.S. HIV, macrophages, glial cells, and cytokines in AIDS nervous system disease. Fedn Am. Socs exp. Biol. J. 5:1991;2391-2397.
35. Merrill J.E., Koyanagi Y., Zack J., Thomas L., Martin F., Chen I.S. Induction of interleukin-1 and tumor necrosis factor alpha in brain cultures by human immunodeficiency virus type 1. J. Virol. 66:1992;2217-2225.
36. Merrill J.E., Ignarro L.J., Sherman M.P., Melinek J., Lane T.E. Microglial cell cytotoxicity of oligodendrocytes is mediated through nitric oxide. J. Immunol. 151:1993;2132-2141.
37. Milligan C.E., Prevette D., Yaginuma H., Homma S., Cardwell C., Fritz L.C., Tomaselli K.J., Oppenheim R.W., Schwartz L.M. Peptide inhibitors of the ICE family arrest programmed cell death of motoneurons in vivo and in vitro. Neuron. 15:1995;385-393.
38. Mucke L., Masliah E., Campbell I.L. Transgenic models to assess the neuropathogenic potential of HIV-1 proteins and cytokines. Curr. Top. Microbiol. Immunol. 202:1995;187-205.
39. Nisticò G., Ciriolo M.R., Fiskin K., Iannone M., De Martino A., Rotilio G. NGF restores decrease in catalase activity and increases superoxide dismutase and glutathione peroxidase activity in the brain of aged rats. Free Rad. Biol. Med. 12:1992;177-181.
40. Paxinos G. and Watson C. (1982) The Rat Brain in Stereotaxic Coordinates. Academic, New York.
41. Penis P., Jett M., Bernton E.W., Boyle T., Gelbard H.A., Dzenko K., Keane R.W., Resnick L., Mizrachi Y., Volsky D.J., Epstein L.G., Gendelman H.E. Cytokines and arachidonic acid metabolites produced during human immunodeficiency virus (HIV)-infected macrophage-astroglia interactions: implications for the neuropathogenesis of HIV disease. J. exp. Med. 176:1992;1703-1718.
42. Pioro E.P., Cuello A.C. Distribution of nerve growth factor receptor-like immunoreactivity in the adult rat central nervous system. Effect of colchicine and correlation with the cholinergic system. I. Neuroscience. 34:1990;57-87.
43. Price R. W. and Perry S. W. (1994) HIV, AIDS, and the Brain. Raven, New York.
44. Relton J.K., Rothwell N.J. Interleukin-1 receptor antagonist inhibits ischemic and excitotoxic neuronal damage in the rat. Brain Res. Bull. 29:1992;243-246.
45. Rosenberg Z.F., Fauci A.S. Immunopathogenetic mechanisms of HIV infection: cytokine induction of HIV expression. Immunol. Today. 11:1990;176-180.
46. Shigeno T., Mima T., Takakura K., Graham D.I., Kato G., Hashimoto Y., Furukawa S. Amelioration of delayed neuronal death in the hippocampus by nerve growth factor. J. Neurosci. 11:1991;2914-2919.
47. Smith-Swintosky V.L., Mattson M.P. Evidence for the expression of functional low affinity and trkA NGF receptors in cultured hippocampal neurones. Soc. Neurosci. Abstr. 18:1992;951.
48. Spencer D.C., Price R.W. Human immunodeficiency virus and the central nervous system. A. Rev. Microbiol. 46:1992;655-693.
49. Spranger M., Lindholm D., Bandtlow C., Heumann R., Gnahn H., Naher-Noè M., Thoenen H. Regulation of nerve growth factor (NGF) synthesis in the rat central nervous system: comparison between the effects of interleukin-1 and various growth factors in astrocyte cultures and in vivo. Eur. J. Neurosci. 2:1990;69-76.
50. Steininger T.L., Wainer B.H., Klein R., Barbacid M., Palfrey H.C. High-affinity nerve growth factor receptor (Trk) immunoreactivity is localized in cholinergic neurons of basal forebrain and striatum in the rat brain. Brain Res. 612:1993;330-335.
51. Strijbos P.J., Rothwell N.J. Interleukin-1beta attenuates excitatory amino acid induced neurodegeneration in vitro: involvement of nerve growth factor. J. Neurosci. 15:1995;3468-3474.
52. Toggas S.M., Masliah E., Rockenstein E.M., Rall G.F., Abraham C.R., Mucke L. Central nervous system damage produced by expression of the HIV-1 coat protein gp120 in transgenic mice. Nature. 367:1994;188-193.
53. Troy C.M., Stefanis L., Prochiantz A., Greene L.A., Shelansky M. The contrasting roles of ICE family and interleukin-1β in apoptosis induced by trophic factor withdrawal and by copper/zinc superoxide dismutase down-regulation. Proc. natn. Acad. Sci. U.S.A. 93:1996;5635-5640.
54. Van Dam A.M., Broune M., Louisse S., Berkenbosch F. Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: a pathway for the induction of non-specific symptoms of sickness? Brain Res. 588:1992;291-296.
55. 2 homodimer. Cell. 78:1994;343-352.
56. Wiley C.A., Masliah E., Morey M., Lemere C., DeTeresa R., Grafe M., Hansen L., Terry R. Neocortical damage during HIV infection. Ann. Neurol. 29:1991;651-657.
57. Yuan J., Shaham S., Ledoux S., Ellis H.M., Horvitz H.R. The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1β-converting enzyme. Cell. 75:1993;641-652.